2022 Michigan Medical Device Summit - Breakout 5
Investing in MedTech: Current State and Future Outlook
The lingering headwinds of the Covid pandemic continue to create uncertainty for medical technology companies, large and small. Predicting patient demand, product sales, provider access, supply chain disruptions, and workforce shortages have become futile as Covid remains a risk and new variants emerge, and let alone other market forces.
So, what does all this look like from an investor's point of view? Hear expert insights from across the funding spectrum on what the markets are saying for early-stage, growth-stage investment, and M&A activity.
Jason Gorak, JPMorgan Chase & Co, Relationship Executive - Life Sciences (Moderator)
Rob Ball, Genesis Innovation Group, CEO
Eli Thomssen, Adlore Inc, President and CEO
Jeff Wesley, Red Cedar Ventures, Executive Director
Advancing Healthcare and Improving Lives Through Medical Technology
The Michigan Medical Device Summit is the annual gathering of the statewide medtech community. It is designed for attendees to learn about the latest in medical device technologies, regulations and marketplace, and especially what Michigan’s cluster has to offer to those developing and manufacturing innovative medical products. Hear the state’s most outstanding medtech and related thought leaders share their perspectives on topics of the day.
Meet and network with medtech sector professionals, academic researchers, healthcare providers and clinicians, suppliers and contract manufacturers, professional services firms, investors, business leaders and government officials, and disruptive companies across all growth stages.
The Summit is intended to better connect and raise the visibility of Michigan’s large medtech cluster including its significant innovation and supply chain assets that are contributing to its steady growth and economic impact. New in 2022 is a showcase of Michigan firms supplying and serving the medtech community.